TRIFLURIDINE and THERAPY PARTIAL RESPONDER

Overview

THERAPY PARTIAL RESPONDER is the #9 most commonly reported adverse reaction for TRIFLURIDINE, manufactured by Sandoz Inc. There are 22 FDA adverse event reports linking TRIFLURIDINE to THERAPY PARTIAL RESPONDER. This represents approximately 2.0% of all 1,094 adverse event reports for this drug.

Patients taking TRIFLURIDINE who experience therapy partial responder should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

THERAPY PARTIAL RESPONDER is a less commonly reported adverse event for TRIFLURIDINE, but still significant enough to appear in the safety profile.

Other Side Effects of TRIFLURIDINE

In addition to therapy partial responder, the following adverse reactions have been reported for TRIFLURIDINE:

• DIARRHOEA — 45 reports
• DRUG INEFFECTIVE — 44 reports
• DEATH — 38 reports
• COLORECTAL CANCER METASTATIC — 31 reports
• NEUTROPENIA — 30 reports
• NAUSEA — 26 reports
• EYE PAIN — 25 reports
• FATIGUE — 25 reports
• DISEASE PROGRESSION — 20 reports
• ANAEMIA — 19 reports

Does TRIFLURIDINE cause THERAPY PARTIAL RESPONDER?

THERAPY PARTIAL RESPONDER has been reported as an adverse event in 22 FDA reports for TRIFLURIDINE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is THERAPY PARTIAL RESPONDER with TRIFLURIDINE?

THERAPY PARTIAL RESPONDER accounts for approximately 2.0% of all adverse event reports for TRIFLURIDINE, making it a notable side effect.

What should I do if I experience THERAPY PARTIAL RESPONDER while taking TRIFLURIDINE?

If you experience therapy partial responder while taking TRIFLURIDINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages